ELEVAI Labs Inc. is a medical aesthetic company developing cutting-edge physician-dispensed skin care applications. The company solves unmet needs in the medical aesthetics space through a combination of cutting-edge science-driven and next-generation consumer applications. ELEVAI Labs Inc. is based in NEWPORT BEACH, Calif.
| Revenue (Most Recent Fiscal Year) | $1.71M |
| Net Income (Most Recent Fiscal Year) | $-6.25M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.19 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.23 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -505406.53% |
| Net Margin (Trailing 12 Months) | -223.41% |
| Return on Equity (Trailing 12 Months) | -77.80% |
| Return on Assets (Trailing 12 Months) | -59.17% |
| Current Ratio (Most Recent Fiscal Quarter) | 8.97 |
| Quick Ratio (Most Recent Fiscal Quarter) | 8.97 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 0.00 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.91 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 1.38M |
| Free Float | 1.37M |
| Market Capitalization | $2.92M |
| Average Volume (Last 20 Days) | 0.39M |
| Beta (Past 60 Months) | -0.95 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.60% |
| Percentage Held By Institutions (Latest 13F Reports) | 22.22% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |